Stock Detail
NANOSPHERE INC
Biotechnology
NSPH @ Yahoo Finance | NSPH Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $1.62 | $1.65 | $0.04 | 2.53% | 0.00 | $1.58 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $1.55 | $1.41 | 159,169 | 71.48M | 336,943 | -1.60 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 1.80 | 1.71 | 1.56 | 1.47 | 1.32 |
Stock Profile
Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform. Its proprietary nanoparticle technology provides the ability to run multiple tests at the same time on the same sample, and enables the development of various test assays to be performed on a single platform. The company is developing diagnostic tests for a range of medical conditions, including cancer, neurodegenerative, cardiovascular, and infectious diseases, as well as pharmaco-genomics or tests for personalized medicine. It is also developing other genomic assays, including tests for cystic fibrosis and a range of infectious diseases. In addition, the company has a program to develop protein tests based on established biomarkers and to validate new biomarkers, in which its ultra-sensitive protein detection technology enables earlier detection of various diseases. Nanosphere was founded in 1998 and is headquartered in Northbrook, Illinois.